These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 19602211)

  • 1. Stored platelet concentrates produced by the platelet-rich plasma method are more resistant to apoptosis but more sensitive to activation than are platelets prepared by the buffy-coat and apheresis methods.
    Leytin V; Allen DJ; Mutlu A; Mykhaylov S; Lyubimov E; Freedman J
    Transfusion; 2009 Jul; 49(7):1493-4. PubMed ID: 19602211
    [No Abstract]   [Full Text] [Related]  

  • 2. Markers of platelet activation and apoptosis in platelet concentrates collected by apheresis.
    Procházková R; Andrýs C; Hubácková L; Krejsek J
    Transfus Apher Sci; 2007 Oct; 37(2):115-23. PubMed ID: 17945536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pooled platelet concentrates: an alternative to single donor apheresis platelets?
    Pietersz RN
    Transfus Apher Sci; 2009 Oct; 41(2):115-9. PubMed ID: 19716340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Impact-R for monitoring the platelet storage lesion.
    Albanyan AM; Murphy MF; Harrison P
    Platelets; 2009 Feb; 20(1):1-6. PubMed ID: 19172514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quality of thrombocyte preparations from buffy coat or platelet-rich plasma].
    Bux J; Müller K; Misterek J; Mueller-Eckhardt C
    Beitr Infusionsther; 1990; 26():99-102. PubMed ID: 1703912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoskeletal reorganization after preparation of platelet concentrates, using the buffy coat method, and during their storage.
    Estebanell E; Diaz-Ricart M; Lozano M; Mazzara R; Escolar G; Ordinas A
    Haematologica; 1998 Feb; 83(2):112-7. PubMed ID: 9549921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF).
    Dohan Ehrenfest DM; Rasmusson L; Albrektsson T
    Trends Biotechnol; 2009 Mar; 27(3):158-67. PubMed ID: 19187989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of platelet concentrates derived by platelet rich plasma, buffy coat and Apheresis.
    Vasconcelos E; Figueiredo AC; Seghatchian J
    Transfus Apher Sci; 2003 Aug; 29(1):13-6. PubMed ID: 12877887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products.
    Li J; de Korte D; Woolum MD; Ruane PH; Keil SD; Lockerbie O; McLean R; Goodrich RP
    Vox Sang; 2004 Aug; 87(2):82-90. PubMed ID: 15355498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
    Skripchenko A; Kurtz J; Moroff G; Wagner SJ
    Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates.
    Dijkstra-Tiekstra MJ; Kuipers W; Setroikromo AC; de Wildt-Eggen J
    Transfusion; 2008 Oct; 48(10):2114-21. PubMed ID: 18647365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in levels of platelet-derived microparticles in platelet components prepared using the platelet rich plasma, buffy coat, and apheresis procedures.
    Noulsri E; Udomwinijsilp P; Lerdwana S; Chongkolwatana V; Permpikul P
    Transfus Apher Sci; 2017 Apr; 56(2):135-140. PubMed ID: 28029568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production.
    Levin E; Culibrk B; Gyöngyössy-Issa MI; Weiss S; Scammell K; LeFresne W; Jenkins C; Devine DV
    Transfusion; 2008 Nov; 48(11):2331-7. PubMed ID: 18631169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical comparison of platelet preparation methods.
    Vassallo RR; Murphy S
    Curr Opin Hematol; 2006 Sep; 13(5):323-30. PubMed ID: 16888436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet storage lesion: an update on the impact of various leukoreduction processes on the biological response modifiers.
    Seghatchian J
    Transfus Apher Sci; 2006 Feb; 34(1):125-30. PubMed ID: 16376152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of random versus apheresis platelet concentrates.
    Andreu G; Vasse J; Sandid I; Tardivel R; Semana G
    Transfus Clin Biol; 2007 Dec; 14(6):514-21. PubMed ID: 18417401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial comparing autologous radiolabeled in vivo platelet (PLT) recoveries and survivals of 7-day-stored PLT-rich plasma and buffy coat PLTs from the same subjects.
    Dumont LJ; Dumont DF; Unger ZM; Siegel A; Szczepiorkowski ZM; Corson JS; Jones MK; Christoffel T; Pellham E; Bailey SL; Slichter SJ;
    Transfusion; 2011 Jun; 51(6):1241-8. PubMed ID: 21214584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolution of platelet procoagulant activity of remnant platelets in stored platelet concentrates prepared by the platelet-rich plasma method and the buffy coat method.
    Van der Planken MG; Vertessen F; Mortelmans E; Van Bockstaele D; Muylle L; Mertens G; Berneman ZN
    Ann Hematol; 1999 Jan; 78(1):1-7. PubMed ID: 10037261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo recovery and survival of apheresis and whole blood-derived platelets: a paired comparison in healthy volunteers.
    Arnold DM; Heddle NM; Kulczycky M; Carruthers J; Sigouin C; Blajchman MA
    Transfusion; 2006 Feb; 46(2):257-64. PubMed ID: 16441604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of the quality of platelet concentrates produced by apheresis procedures, platelet rich plasma, and buffy coat.
    Li M; Zhao Y; Chen X; Du X; Luo Y; Li Y; Kang J; Wan L; Tang J; Fu X
    Transfusion; 2024 Feb; 64(2):367-379. PubMed ID: 38174435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.